Broader usage of combinations in daily clinical practice: what benefits for patients?

31 August 2020 (18:44 - 18:52)

Organised by:

Video

Slides

Sign in to view the resources

About the speaker

Professor Alberto Zambon

Padova University Hospital, Padua (Italy)

6 More presentations in this session

Presentation thumbnail

ESC Guidelines 2019: what has changed?

Professor A. Zambon (Padua, IT)

Presentation thumbnail

What is the key evidence supporting LDL-C control at lower targets, with earlier intervention for better outcomes in the long-term?

Professor L. Perez De Isla (Madrid, ES)

Presentation thumbnail

How have the French and Spanish (local) Cardiology Societies interpreted the ESC Guidelines? Insights and recommendations.

Professor L. Perez De Isla (Madrid, ES)

Presentation thumbnail

Statin/ezetimibe combinations: data and evidence, for which patients.

Professor A. Zambon (Padua, IT)

Presentation thumbnail

Feedback on patients treated with high intensity statin/ezetimibe combinations. Do we need to go further?

Professor A. Zambon (Padua, IT)

Access the full session

Session thumbnail

Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy

The Event

ESC Congress 2020

31 August 2020 18:44 CET

You may be interested in

Congress Presentation

Early use of triple single pill combination: make it a habit

30 August 2025

Congress Presentation

Combination therapy rapidly improves symptoms and quality of life in recently diagnosed angina patients: the COMBINE Angina study

1 September 2025

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

19 July 2023

Congress Session

Innovative drug therapies in heart failure

18 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources